REFERENCES
- US Renal Data System, USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2009.
- Krishnamurthy G, Kher V, Naik S. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells. Scand J Urol Nephrol. 2002;36:377–382.
- Maisonneuve P, Agodoa L, Gellert R, Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet. 1999;354:93–99.
- Selroos O, Pasternack A, Virolainen M. Skin test sensitivity and antigen-induced lymphocyte transformation in uraemia. Clin Exp Immunol. 1973;14:365–370.
- Costa E, Lima M, Alves JM, Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J Clin Immunol. 2008;28:268–275.
- Costa E, Rocha S, Rocha-Pereira P, Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients. Am J Nephrol. 2008;28:935–940.
- Meier P, Dayer E, Blanc E, Wauters JP. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol. 2002;13:204–212.
- Litjens N, Druningen CJ, Betjes MGH. Progressive loss of renal function is associated with activation and depletion of naïve T lymphocytes. Clin Immunol. 2006;118:83–91.
- Girndt M, Sester M, Sester U, Kaul H, Köhler H. Molecular aspects of T and B cell function in uremia. Kidney Int. 2001;59:206–211.
- Brenchley JM, Karandikar NJ, Betts MR, Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 2003;101:2711–2720.
- Wood KL, Twigg HL, III, Doseff AI. Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation. Front Biosci. 2009;14:3771–3781.
- Wood KL, Knox KS, Wang Y, Day RB, Schnizlein-Bick C, Twigg HL, III. Apoptosis of CD57+ and CD57− lymphocytes in the lung and blood of HIV-infected subjects. J Clin Immunol. 2005;117:294–301.
- Shinomiya N, Koike Y, Koyama H, Analysis of the susceptibility of CD 57+ T cells to CD3-mediated apoptosis. Clin Exp Immunol. 2004;139:268–278.
- Calopa M, Bas J, Callén A, Mestre M. Apoptosis of peripheral blood lymphocytes in Parkinson patients. Neurobiol Dis. 2010;38:1–7.
- Katz O, Lindor G, Lifshitz L, Erythropoietin enhances immune responses in mice. Eur J Immunol. 2007;37:1584–1593.
- Prutchi-Sagiv S, Neumann D, Mittelman M. Erythropoietin as an Immunotherapeutic agent: New uses for an old drug? Med Hypotheses Res. 2005;2:587–596.
- Ueki Y, Nagata M, Miyake S, Tominaga Y. Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin. J Clin Immunol. 1993;4:179–287.
- Kurz P, Köhler H, Meuer S, Hütteroth T, Meyer Zum Büshenfeld KH. Impaired cellular immune responses in chronic renal failure: Evidence for a T cell defect. Kidney Int. 1986;29:1209–1214.
- Yoon JW, Gollapudi S, Pahl MV, Vaziri ND. Naïve and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int. 2006;70:371–376.
- Sardenberg C, Suassuna P, Andreoli MCC, Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephrol Dial Transplant. 2006;21:160–165.
- Carracedo J, Ramírez R, Soriano S, Martín-Malo A, Rodríguez M, Aljama P. Caspase-3-dependent pathway mediates apoptosis of human mononuclear cells induced by cellulosic hemodialysis membranes. Nephrol Dial Transplant. 2002;17:1971–1977.
- Palmer BE, Blyveis N, Fontenot AP, Wilson CC. Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction. J Immunol. 2005;175:8415–8423.
- Trzonkowski P, Debska-Slizien A, Szmit E, Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in hemodialysis patients. Nephrol Dial Transplant. 2005;20:367–376.